Causaly Secures $60M to Speed up AI-Powered Biomedical Analysis
What You Ought to Know: Causaly, the main AI platform for biomedical analysis raises $60M in Sequence B funding led...
What You Ought to Know: Causaly, the main AI platform for biomedical analysis raises $60M in Sequence B funding led...
An Sanofi and AstraZeneca antibody drug designed to guard infants from growing infections from respiratory syncytial virus (RSV) has acquired...
DrDoctor, the UK’s main affected person engagement platform (PEP) provider, has secured £10 million of funding to advance its plans...
UK startup Re:course AI has introduced a seed funding spherical of $4.3m led by Par Fairness to develop a synthetic...